Clinical Trials Browser

NETWORK × Bortezomib × Thoracic × Clear all

NCT00458913 2018-07-12

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00513877 2014-12-31

Bortezomib in Treating Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00516100 2010-01-15

Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC

Phase 1/2 Unknown

Carcinoma, Non-Small-Cell Lung